BAUM MARK L 13D/13G Filings for IMPRIMIS PHARMACEUTICALS, INC. (IMMY)

BAUM MARK L 13D and 13G filings for IMPRIMIS PHARMACEUTICALS, INC.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-04-27
5:25 pm
Purchase
2021-04-2513DIMPRIMIS PHARMACEUTICALS, INC.
IMMY
BAUM MARK L2,367,072
8.600%
897,662increase
(+61.09%)
Filing